Company intelligence / Profile preview

Shenzhen Jiadao Gongcheng Equity Investment Fund

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Shenzhen Jiadao Gongcheng Equity Investment Fund is an RMB private equity/venture capital fund that makes equity investments and acquisitions in life science and other sectors; it does not develop drugs itself, so it has no clinical results or pipeline.

Industry: Investors

Partnerships

CASI Biopharmaceuticals (Wuxi) Co., Ltd.Juventas Biotechnology (Tianjin) Co., Ltd.

Beyond the preview

Go deeper on Shenzhen Jiadao Gongcheng Equity Investment Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen Jiadao Gongcheng Equity Investment Fund.

Explore the full profile